Librizzi M, Naselli F, Abruscato G, Luparello C, Caradonna F
Biology (Basel). 2023; 12(7).
PMID: 37508381
PMC: 10376784.
DOI: 10.3390/biology12070950.
Yao S, Du Z, Xiao L, Yan F, Ivanovski S, Xiao Y
Biomolecules. 2023; 13(1).
PMID: 36671434
PMC: 9856050.
DOI: 10.3390/biom13010049.
Hatch J, Segvich D, Kohler R, Wallace J
Bone Rep. 2022; 17:101609.
PMID: 35941910
PMC: 9356200.
DOI: 10.1016/j.bonr.2022.101609.
Leanza G, Fontana F, Lee S, Remedi M, Schott C, Ferron M
J Bone Miner Res. 2021; 36(7):1403-1415.
PMID: 33831261
PMC: 8360087.
DOI: 10.1002/jbmr.4303.
Hildebrandt N, Colditz J, Dutra C, Goes P, Salbach-Hirsch J, Thiele S
Sci Rep. 2021; 11(1):1920.
PMID: 33479403
PMC: 7820472.
DOI: 10.1038/s41598-021-81543-7.
Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes.
Yang M, Song B, Liu J, Bing Z, Wang Y, Yu L
PeerJ. 2020; 8:e10297.
PMID: 33240632
PMC: 7666560.
DOI: 10.7717/peerj.10297.
Bone health in diabetes and prediabetes.
Costantini S, Conte C
World J Diabetes. 2019; 10(8):421-445.
PMID: 31523379
PMC: 6715571.
DOI: 10.4239/wjd.v10.i8.421.
Differential effects of type 1 diabetes mellitus and subsequent osteoblastic β-catenin activation on trabecular and cortical bone in a mouse model.
Chen S, Liu D, He S, Yang L, Bao Q, Qin H
Exp Mol Med. 2018; 50(12):1-14.
PMID: 30518745
PMC: 6281645.
DOI: 10.1038/s12276-018-0186-y.
Parathyroid hormone-related protein exhibits antioxidant features in osteoblastic cells through its N-terminal and osteostatin domains.
Portal-Nunez S, Ardura J, Lozano D, Martinez de Toda I, de la Fuente M, Herrero-Beaumont G
Bone Joint Res. 2018; 7(1):58-68.
PMID: 29330344
PMC: 5805825.
DOI: 10.1302/2046-3758.71.BJR-2016-0242.R2.
Exploiting the WNT Signaling Pathway for Clinical Purposes.
Johnson M, Recker R
Curr Osteoporos Rep. 2017; 15(3):153-161.
PMID: 28432596
DOI: 10.1007/s11914-017-0357-0.
Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation.
Osagie-Clouard L, Sanghani A, Coathup M, Briggs T, Bostrom M, Blunn G
Bone Joint Res. 2017; 6(1):14-21.
PMID: 28062525
PMC: 5227055.
DOI: 10.1302/2046-3758.61.BJR-2016-0085.R1.
Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
Tsentidis C, Gourgiotis D, Kossiva L, Marmarinos A, Doulgeraki A, Karavanaki K
Osteoporos Int. 2016; 28(3):945-953.
PMID: 27766367
DOI: 10.1007/s00198-016-3802-5.
Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
Kalaitzoglou E, Popescu I, Bunn R, Fowlkes J, Thrailkill K
Curr Osteoporos Rep. 2016; 14(6):310-319.
PMID: 27704393
PMC: 5106298.
DOI: 10.1007/s11914-016-0329-9.
Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus.
Pereira M, Gohin S, Lund N, Hvid A, Smitham P, Oddy M
Osteoporos Int. 2016; 28(1):309-320.
PMID: 27468901
PMC: 5206261.
DOI: 10.1007/s00198-016-3718-0.
Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition.
Epstein S, Defeudis G, Manfrini S, Napoli N, Pozzilli P
Osteoporos Int. 2016; 27(6):1931-51.
PMID: 26980458
DOI: 10.1007/s00198-015-3454-x.
The Effects of Chinese Medicine on Activation of Wnt/β-Catenin Signal Pathway under High Glucose Condition.
Liu W, Liang X, Yang D
Evid Based Complement Alternat Med. 2015; 2015:295135.
PMID: 26495008
PMC: 4606185.
DOI: 10.1155/2015/295135.
Type 1 diabetes and osteoporosis: from molecular pathways to bone phenotype.
Khan T, Fraser L
J Osteoporos. 2015; 2015:174186.
PMID: 25874154
PMC: 4385591.
DOI: 10.1155/2015/174186.
Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice.
Zhukouskaya V, Eller-Vainicher C, Shepelkevich A, Dydyshko Y, Cairoli E, Chiodini I
J Endocrinol Invest. 2015; 38(9):941-50.
PMID: 25863666
DOI: 10.1007/s40618-015-0284-9.
Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
Coe L, Tekalur S, Shu Y, Baumann M, McCabe L
J Cell Physiol. 2015; 230(8):1944-53.
PMID: 25641511
PMC: 4724196.
DOI: 10.1002/jcp.24929.
Interruption of Wnt signaling in Müller cells ameliorates ischemia-induced retinal neovascularization.
Zhou K, Benyajati S, Le Y, Cheng R, Zhang W, Ma J
PLoS One. 2014; 9(10):e108454.
PMID: 25271989
PMC: 4182699.
DOI: 10.1371/journal.pone.0108454.